
United States · Information technology & services startup
Mendel.ai is a clinical AI platform based in San Jose, California, focused on enhancing clinical data workflows for life sciences and healthcare organizations.
Funding reportedLast round: Series B
Follow mendel.ai and see its new rounds in your feed.Start following
Mendel.ai is a clinical AI platform based in San Jose, California, focused on enhancing clinical data workflows for life sciences and healthcare organizations.
Founded in 2016, the company combines large language models with a proprietary clinical hypergraph to provide scalable and explainable clinical reasoning. Its mission is to streamline global oncology research by organizing real-world data and automating clinical trials. The company offers a suite of clinical-specific data processing products, primarily centered around its Hypercube Platform. This platform enables organizations to analyze patient data using everyday language and includes features such as clinical natural language processing, automated redaction of patient health information, and tools for matching patient records to clinical trials. Mendel.ai serves a diverse range of clients, including biopharma companies, healthcare providers, and clinical research institutions, and emphasizes its commitment to delivering trustworthy and auditable outputs in clinical data analysis.
Funding, as reported
What they build
Known for
de-identificationhealth careai-driven researchdata curationclinical data graph reasoningclinical workflows automationmedical record reviewai for multi-modal dataclinical data reasoningphi redactionmedical data processinghealthcare data transformationhealthcare data standardizationcomputer & network securityclinical reasoninghypergraph ai innovation
Built with from their website
Google WorkspaceCloudFlareWebflow HostingAIGoogle MeetCloudFlare CDNCloudflare DNSWizZendesk for ServiceGoDaddy Domains
Amazon AWSZendeskMicrosoft 365GoDaddy HostingZendesk Support SuiteGoogle Search ConsoleGmail
Add your raise, your deck and your story, and put mendel.ai in front of investors. Or tell us what we have wrong.